The prevalence and use of antidepressant medication in pediatric cancer patients

Journal of Child and Adolescent Psychopharmacology

Volumn 16, Issue 4, 2006, Pages 467-473

  Portteus, Andrew ^a,b,c   Ahmad, Naveed ^b   Tobey, Daniel ^a,b   Leavey, Patrick ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; OLANZAPINE; OPIATE; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL OBSERVATION; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; MALE; MOOD DISORDER; PREVALENCE; PROSPECTIVE STUDY; RACE; REVIEW; SEX DIFFERENCE;

ADOLESCENT; ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS; CHILD; COMORBIDITY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG UTILIZATION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LIKELIHOOD FUNCTIONS; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS; SICK ROLE;

EID: 33750586078     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.16.467     Document Type: Review

References (28)

1. Allen R, Newman SP, Souhami RL: Anxiety and depression in adolescent cancer: Findings in patients and parents at the time of diagnosis. Eur J Cancer 33:1250-1255, 199 7.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
3. Apter A, Farbstein I, Yaniv I: Psychiatric aspects of pediatric cancer. Child Adolesc Psychiatr Clin N Am 12:473-492, vii, 2003.
4. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, Perel J, Nelson B: Childhood and adolescent depression: A review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 35:1427-1439, 1996.
5. Cairns NU, Clark GM, Smith SD, Lansky SB: Adaptation of siblings to childhood malignancy. J Pediatr 95:484-487, 1979.
6. Çavuşoǧlu H: Depression in children with cancer. J Pediatr Nurs 16:380-385, 2001.
7. Dunitz M, Scheer PJ, Wurst L, Grientschnigg G, Urban EC: Depression in children with cancer. Padiatr Padol 26:267-270, 1991.
8. Eiser C, Hill JJ, Vance YH: Examining the psychological consequences of surviving childhood cancer: Systematic review as a research method in pediatric psychology. J Pediatr Psychol 25:449-460, 2000.
9. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson JG: Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205-1215, 2002.
10. Emslie GJ, Portteus AM, Kumar EC, Hume JH: Antidepressants: SSRIs and Novel Atypical Antidepressants-an Update on Psychopharmacology, chapter 12. In: Handbook of Mental Health Interventions in Children and Adolescents: An integrated developmental approach. Edited by Steiner H. San Francisco (California), Josey-Bass, 2004a.
11. Emslie G: Clinical guidelines vs. clinical trials. J Child Adolesc Psychopharmacol 14:5-7, 2004b.
12. Fisch M: Treatment of depression in cancer. J Natl Cancer Inst. Monogr 105-111, 2004.
13. Kashani J, Hakami N: Depression in children and adolescents with malignancy. Can J Psychiatry 27:474-477, 1982.
14. Kaufman KL, Harbeck C, Olson R, Nitschke R: The availability of psychosocial interventions to children with cancer and their families. Child Health Care 21:21-25, 1992.
15. Kusch M, Labouvie H, Ladisch V, Fleischhack G, Bode U: Structuring psychosocial care in pediatric oncology. Patient Educ Couns 40:231-245, 2000.
16. Manne SL, Lesanics D, Meyers P, Wollner N, Steinherz P, Redd W: Predictors of depressive symptomatology among parents of newly diagnosed children with cancer. J Pediatr Psychol 20:491-510, 1995.
17. Olfson M, Gameroff MJ, Marcus SC, Waslick BD: Outpatient treatment of child and adolescent depression in the United States. Arch Gen Psychiatry 60:1236-1242, 2003.
18. Patenaude AF, Kupst MJ: Psychosocial functioning in pediatric cancer. J Pediatr Psychol 30:9-27, 2005.
19. rd edition. American Psychiatric Press, Inc., 2000.
20. Sasaki T, Akaho R, Sakamaki H, Akiyama H, Yoshino M, Hagiya K, Atsumi M: Mental disturbances during isolation in bone marrow transplant patients with leukemia. Bone Marrow Transplantation 25:315-318, 2000.
21. Schreiber S, Backer MM, Yanai J, Pick CG: The antinociceptive effect of fluvoxamine. Eur Neuropsychopharmacol 6:281-284, 1996.
22. Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME, Lahey BB, Bourdon K, Jensen PS, Bird HR, Canino G, Regier DA: The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry 35:865-877, 1996.
23. Sharan P, Mehta M, Chaudhry VP: Psychiatric morbidity in children suffering from acute lymphoblastic leukemia. Pediatr Hematol Oncol 16:49-54, 1999.
24. Singh VP, Jain NK, Kulkarni SK: On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res 915:218-226, 2001.
25. Slater JA: Psychiatric aspects of cancer in childhood and adolescence. In: Child and Adolescent Psychiatry. Third Edition. Edited by Lewis M, Philadelphia, Lippincott Williams and Wilkins, 2002.
26. Stam H, Grootenhuis MA, Last BF: Social and emotional adjustment in young survivors of childhood cancer. Support Care Cancer 9:489-513, 2001.
27. th edition. Boston (Massachusetts), Allyn and Bacon, 2001.
28. Zebrack BJ, Gurney JG, Oeffinger K, Whitton J, Packer RJ, Mertens A, Turk N, Castleberry R, Dreyer Z, Robison LL, Zeltzer LK: Psychological outcomes in long-term survivors of childhood brain cancer: A report from the childhood cancer survivor study. J Clin Oncol 22:999-1006, 2004.